Scott Tarriff
CIK 1469124 · CEO · last filed 2024-03-01
Scott Tarriff is a CEO who has filed 54 SEC Form 4 insider transactions across 4 companies since 2009. The most recent filing shows the insider had shares withheld for taxes covering $13.3K of EGRX on Mar 1, 2024. Across all open-market trades the lifetime net is −$24.4M, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
4
54
-$24.37M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted | CEO | 1,453,244 | $2.14 | $3.11M | -$24.37M | 37 | 2024-03-01 |
| Alaunos Therapeutics, Inc. (ZIOP) Delisted | Director | 4,186 | $0.87 | $3.6K | $0 | 6 | 2020-01-03 |
| Theriva Biologics, Inc. (SYN) Delisted | Director | 300,000 | $1.02 | $306.0K | $0 | 8 | 2019-12-06 |
| CLINICAL DATA INC (CLDA) Delisted | Director | 0 | — | — | $0 | 3 | 2011-04-14 |
Recent Filings
54 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-03-01 | EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted | Tax (F) | −2,119 | -$13.3K | EDGAR |
| 2024-02-29 | EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted | Mixed | +9,796 | -$20.3K | EDGAR |
| 2024-01-09 | EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted | Tax (F) | −4,322 | -$22.2K | EDGAR |
| 2023-11-03 | EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted | Sell (S) | −21,619 | -$299.3K | EDGAR |
| 2023-10-04 | EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted | Sell (S) | −20,245 | -$300.0K | EDGAR |
| 2023-05-18 | EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted | Sell (S) | −15,000 | -$299.7K | EDGAR |
| 2023-05-15 | EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted | Sell (S) | −45,000 | -$930.7K | EDGAR |
| 2023-03-02 | EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted | Mixed | +67,787 | -$87.2K | EDGAR |
| 2023-01-24 | EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted | Tax (F) | −3,732 | -$125.5K | EDGAR |
| 2023-01-09 | EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted | Tax (F) | −3,827 | -$112.0K | EDGAR |